Sixteen partners from 10 European countries got together to create the “Nanomedicine for Atherosclerosis” consortium. Its aim is to study and develop the clinical feasibility of nanomedicine for targeted diagnosis and treatment of atherosclerosis. Coordinated by Inserm, the project has just obtaining funding amounting to 10 million euros over five years from the European Commission. […]
Excess body weight (overweight and obesity) currently concerns nearly one in two French adults. It is associated with an increased risk of several primary cancers, including postmenopausal breast cancer. Researchers at an Inra-Inserm-Cnam-Université Paris 13 joint research unit, part of NACRe(1), worked with a team from Imperial College London to carry out the first systematic […]
